The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. National Institutes of Health [U10 CA98543, U10 CA180886, U10 CA98413, U10 CA180899, U24 CA114766, U24-CA196173]
2. American Lebanese Syrian Associated Charities
3. Innovation Grant of Alex's Lemonade Stand Foundation
4. Frank A. Campini Foundation